143 related articles for article (PubMed ID: 26431176)
21. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma].
Pang D; Zhao X; Xue Y
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327
[TBL] [Abstract][Full Text] [Related]
22. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483
[TBL] [Abstract][Full Text] [Related]
24. [Expression of the cyclooxygenase-2 gene in human breast carcinoma].
Zhao XQ; Pang D; Xue YW
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):427-9. PubMed ID: 12895350
[TBL] [Abstract][Full Text] [Related]
25. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
Díaz-Cruz ES; Shapiro CL; Brueggemeier RW
J Clin Endocrinol Metab; 2005 May; 90(5):2563-70. PubMed ID: 15687328
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy.
O'Connor JK; Avent J; Lee RJ; Fischbach J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1034-40. PubMed ID: 15001242
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.
Shim V; Gauthier ML; Sudilovsky D; Mantei K; Chew KL; Moore DH; Cha I; Tlsty TD; Esserman LJ
Cancer Res; 2003 May; 63(10):2347-50. PubMed ID: 12750248
[TBL] [Abstract][Full Text] [Related]
31. Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial.
Ellis MJ; Miller WR; Tao Y; Evans DB; Chaudri Ross HA; Miki Y; Suzuki T; Sasano H
Breast Cancer Res Treat; 2009 Jul; 116(2):371-8. PubMed ID: 18941892
[TBL] [Abstract][Full Text] [Related]
32. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
[TBL] [Abstract][Full Text] [Related]
33. Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.
Davies G; Salter J; Hills M; Martin LA; Sacks N; Dowsett M
Clin Cancer Res; 2003 Jul; 9(7):2651-6. PubMed ID: 12855643
[TBL] [Abstract][Full Text] [Related]
34. Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.
Sivula A; Talvensaari-Mattila A; Lundin J; Joensuu H; Haglund C; Ristimäki A; Turpeenniemi-Hujanen T
Breast Cancer Res Treat; 2005 Feb; 89(3):215-20. PubMed ID: 15754118
[TBL] [Abstract][Full Text] [Related]
35. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
36. Expression of cyclooxygenase-1 and -2 in human breast cancer.
Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K
Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950
[TBL] [Abstract][Full Text] [Related]
37. Expression of COX-2 and steroid converting enzymes in breast cancer.
Gunnarsson C; Jansson A; Holmlund B; Ferraud L; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Oncol Rep; 2006 Aug; 16(2):219-24. PubMed ID: 16820896
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer.
Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2006 Apr; 118(8):1915-21. PubMed ID: 16287071
[TBL] [Abstract][Full Text] [Related]
39. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
40. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells.
Santner SJ; Pauley RJ; Tait L; Kaseta J; Santen RJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):200-8. PubMed ID: 8989259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
